导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 25.31% | 152/1050 |
| 近一周 | -2.90% | 777/1104 |
| 近一月 | -8.37% | 942/1102 |
| 近一季 | -19.56% | 966/1092 |
| 近半年 | 21.08% | 130/1070 |
| 近一年 | 27.16% | 175/1018 |
| 近两年 | 104.71% | 174/926 |
| 近三年 | 71.62% | 141/834 |
| 成立以来 | 100.13% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-0.01% 484/1070 |
77.51% 119/1101 |
- - |
- - |
| 2025 | 44.24% 253/1065 |
2.01% 646/1014 |
1.95% 512/1038 |
38.60% 221/1050 |
0.08% 450/1065 |
| 2024 | -1.32% 620/1011 |
-0.02% 317/960 |
-0.85% 366/983 |
2.83% 921/991 |
-3.19% 549/1011 |
| 2023 | -12.17% 404/952 |
9.71% 123/880 |
4.38% 41/895 |
-17.56% 826/915 |
-6.96% 669/952 |
| 2022 | -32.67% 675/867 |
-20.99% 576/773 |
6.34% 443/806 |
-14.41% 530/845 |
-6.37% 679/867 |
| 2021 | 4.48% 311/740 |
-5.93% 382/580 |
13.81% 262/659 |
1.06% 204/704 |
-3.43% 552/740 |
| 2020 | 77.90% 102/554 |
12.86% 31/419 |
28.82% 141/466 |
5.68% 351/517 |
15.79% 187/554 |
| 2019 | 59.28% 84/410 |
32.35% 252/1149 |
1.17% 230/1231 |
8.66% 137/390 |
9.48% 176/410 |
| 2018 | -30.78% 230/349 |
- - |
- - |
- - |
-15.10% 880/1080 |
| 2017 | 24.56% 66/285 |
- - |
- - |
- - |
- - |
| 2016 | -25.99% 139/205 |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票C | 0.8165 | 61.04% |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商医药健康产业股票 | 2.6450 | 53.78% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 嘉实医疗保健股票 | 2.6190 | 42.34% |
| 前海开源公共卫生股票C | 0.4647 | 42.24% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 广发医药精选股票C | 1.3103 | 40.86% |
| 交银医药创新股票C | 3.0948 | 37.26% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 摩根新兴服务股票A VS. 东吴新产业精选股票A(580008) |